Differences in exoenzyme production and adherence ability of candida spp. isolates from catheter, blood and oral cavity

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 52, Issue 3, 2010, Pages 139-143

  Costa, Carolina Rodrigues ^a   Passos, Xisto Sena ^a   Souza, Lúcia Kioko Hasimoto ^b   Lucena, Percilia de Andrade ^b   Fernandes, Orionalda de Fátima Lisboa ^b   Silva, Maria do Rosário Rodrigues ^b  

^a PAULISTA UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Adherence ability; Candida; Exoenzyme activity

Indexed keywords

BOVINE SERUM ALBUMIN; PHOSPHOLIPASE; PROTEINASE; ASPARTIC PROTEINASE;

ARTICLE; BLOOD SAMPLING; CANDIDA; CANDIDA ALBICANS; CATHETER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SYNTHESIS; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; INOCULATION; INTENSIVE CARE UNIT; MICROBIAL ACTIVITY; MOUTH MUCOSA; NONHUMAN; PATHOGENICITY; BACTERIUM ADHERENCE; BIOSYNTHESIS; ENZYMOLOGY; EPITHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUTH; PHYSIOLOGY;

ASPARTIC ACID PROTEASES; BACTERIAL ADHESION; CANDIDA; CATHETERS, INDWELLING; EPITHELIAL CELLS; HIV INFECTIONS; HUMANS; MOUTH; PHOSPHOLIPASES;

EID: 77954851824     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652010000300005     Document Type: Article

References (29)

1. Akgül O, Çerikçioglu N. Hypertonic Sabouraud dextrose agar as a substrate for differentiation of Candida dubliniensis. Mycopathologia. 2009;167:357-9.
2. Alves SH, Milan EP, Sant ́Ana PL, Oliveira LO, Santurio JM, Colombo AL. Hypertonic Sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis. 2002;43:85-6.
3. Biasoli MS, Tosello ME, Magaró HM. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses. 2002;45:465-9.
4. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9:327-35.
5. Cavassani VGS, Andrade Sobrinho JA, Homem MGN, Rapoport A. Candidíase oral como marcador de prognóstico em pacientes portadores do HIV. Rev Bras Otorrinolaringol. 2002;68:630-4.
6. Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalized patients. Mycoses. 2005;48:321-6.
7. Dolapci I, Tekeli A, Gocmen JS, Aysev D, Guriz H. Investigation of Candida dubliniensis in Candida spp.-positive hemocultures. APMS. 2002;110:391-5.
8. Faggi E, Pini G, Campisi E, Martinelli C, Difonzo E. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection. Mycoses. 2005;48:211-5.
9. Fotedar R, Al-Hedaithy SSA. C. dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol. 2003;41:1907-11.
10. Fotedar R, Al-Hedaithy SSA. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis. Mycoses. 2005;48:62-7.
11. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia. 2007;164:265-9.
12. Henriques M, Azeredo J, Oliveira R. The involvement of physico-chemical interactions in the adhesion of Candida albicans and Candida dubliniensis to epithelial cells. Mycoses. 2007;50:391-6.
13. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-30.
14. Kantarcioglu AS, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses. 2002;45:160-5.
15. Kennedy MJ. Adhesion and association mechanisms of Candida albicans. Curr Top Med Mycol. 1988;2:73-169.
16. Koga-Ito CY, Lyon JP, Vidotto V, Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia. 2006;161:219-23.
17. Kumar CPG, Kumar SSJ, Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia. 2006;161: 213-8.
18. th ed. Amsterdam: Elsevier; 1998.
19. Lyon JP, Resende MA. Evaluation of adhesion to buccal epithelial cells in Candida species obtained from denture wearers after exposure to fluconazole. Mycoses. 2007;50:21-4.
20. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67:400-28.
21. Niewerth M, Korting HC. Phospholipases of Candida albicans. Mycoses. 2001;44:361-7.
22. Pongsiriwet S, Iamaroon A, Sriburee P, Pattanaporn K, Krisanaprakornkit S. Oral colonization of Candida species in perinatally HIV-infected children in northern Thailand. J Oral Sci. 2004;46:101-5.
23. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982;20:7-14.
24. Resende JCP, Resende MA, Saliba JL. Prevalence of Candida spp. in hospitalized patients and their risk factors. Mycoses. 2002;45:306-12.
25. Ruchel R, Tegeler R, Trost M. A comparison of secretory proteinase from different strains of Candida albicans. Sabouraudia. 1982;20:233-44.
26. Sturtevant J, Calderone R. Candida albicans adhesins: biochemical aspects and virulence. Rev Iberoamer Micol. 1997;14:90-7.
27. Urizar JMA. Candidiasis orales. Rev Iberoam Micol. 2002;19:17-21.
28. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-17.
29. Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect. 2003;36:223-8.